*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Voxilaprevir intermediate is a key synthetic precursor for the direct-acting antiviral drug Voxilaprevir, primarily utilized in the pharmaceutical manufacturing of Hepatitis C treatments. The core process involves chiral synthesis and amide coupling. <strong>Molecular Formula: C24H29N5O4</strong>. <strong>CAS No.: 1687070-93-8</strong>.</p>
<h3>Application</h3>
<ul>
<li>Pharmaceutical API production for HCV protease inhibitors.</li>
<li>R&D scale-up for novel antiviral combination therapies.</li>
<li>Contract manufacturing organization (CMO) supply chains.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly store under inert atmosphere at controlled temperatures below 25°C to prevent hydrolysis. Personnel must utilize appropriate PPE including respirators and chemical-resistant gloves due to potential sensitization risks during handling.</p>